Strengthening Product Development Capabilities
First written in FY2016. 16 of 24 entries say "Advanced", first in FY2017. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「Filing company Head office (Onojo, Fukuoka Prefecture) Electric beds for medical and nursing care business Tooling 80,000 - Internal funds October 2026 March 2027」
The company presented a specific plan to invest ¥80 million in tooling for new products from October 2026 through March 2027. Research and development expenses amounted to ¥23 million. - FY2025AdvancedAnnual report
「The Group's total capital expenditure in the electric beds for medical and nursing care business during the consolidated fiscal year was ¥224 million. The principal items were ¥75 million in leased assets, ¥63 million in machinery and equipment, and ¥62 million in buildings and structures.」
The company made ¥224 million in capital expenditures during the year, and research and development expenses were ¥27.712 million. It presented a plan to invest ¥50 million in molds for new products from July to December 2025. - FY2024AdvancedAnnual report
「Reporting company: Head office (Onojo, Fukuoka Prefecture); electric beds for medical and nursing care business; molds; ¥50 million; —; internal funds; October 2024 to March 2025」
A new plan was presented to invest ¥50 million in molds for new products from October 2024 to March 2025. Research and development expenses were also ¥26 million. - FY2023AdvancedAnnual report
「Reporting company: Head office (Onojo, Fukuoka Prefecture); electric beds for medical and nursing care business; molds; ¥50 million; internal funds; January 2024 to June 2024」
A specific plan was presented to invest ¥50 million in molds for new products from January to June 2024. Total capital expenditure for the year was ¥99 million, and research and development expenses were ¥13 million. - FY2023-Q2WorsenedAnnual report
「Against this backdrop, sales in the welfare equipment distribution market during the cumulative second-quarter period fell 11.4% year on year to ¥2,219 million, partly because customers' demand declined following the product price increases in October 2022.」
Sales in the welfare equipment distribution market fell 11.4% year on year as customers' demand declined following the product price increases. - FY2023-Q1Continued end of demand for the main product led to lower salesAnnual report
「Against this backdrop, demand for the Group's main product, Miolet III, an electric bed for nursing care, had run its course approximately 3 years after launch. As a result, sales in the welfare equipment distribution market during the cumulative first-quarter period fell 2.4% year on year to ¥1,164 million.」
The decline in sales due to demand for Miolet III having run its course continued. The decline in the welfare equipment distribution market was 2.4% year on year, narrowing from the 14.9% decline for FY2022 as a whole. - FY2022WorsenedAnnual report
「Against this backdrop, demand for the Group's main product, Miolet III, an electric bed for nursing care, had run its course approximately 3 years after launch, while the launch of new products was delayed. As a result, full-year sales in the welfare equipment distribution market fell 14.9% year on year to ¥4,641 million.」
The end of demand for the main product Miolet III and delays in launching new products caused full-year sales in the welfare equipment distribution market to fall 14.9% year on year to ¥4,641 million. - FY2022-Q3WorsenedAnnual report
「Against this backdrop, shipments of the Group's main product, Miolet III, an electric bed for nursing care, remained strong. However, demand had run its course approximately 3 years after the product's launch, and sales in the welfare equipment distribution market during the cumulative third-quarter period fell 12.6% year on year to ¥3,545 million.」
Shipments of the main product Miolet III were strong, but demand had run its course approximately 3 years after launch, causing sales in the welfare equipment distribution market to fall 12.6% year on year to ¥3,545 million. - FY2022-Q2WorsenedAnnual report
「Against this backdrop, shipments of the Group's main product, Miolet III, an electric bed for nursing care, remained strong. However, demand had run its course approximately 3 years after the product's launch, and sales in the welfare equipment distribution market during the cumulative second-quarter period fell 10.5% year on year to ¥2,505 million.」
Shipments of the main product Miolet III were strong, but demand had run its course approximately 3 years after launch, causing sales in the welfare equipment distribution market to fall 10.5% year on year to ¥2,505 million. - FY2022-Q1WorsenedAnnual report
「Against this backdrop, shipments of the Group's main product, Miolet III, an electric bed for nursing care, remained strong. However, demand had run its course approximately 3 years after the product's launch, and sales in the welfare equipment distribution market during the cumulative first-quarter period fell 11.1% year on year to ¥1,193 million.」
Shipments of the main product Miolet III remained strong, but demand had run its course approximately 3 years after launch, causing sales in the welfare equipment distribution market to fall 11.1% year on year to ¥1,193 million. - FY2021AdvancedAnnual report
「Reporting company: Head office (Onojo, Fukuoka Prefecture); electric beds for medical and nursing care business; molds; ¥100 million; internal funds; September 2021 to December 2021」
A specific plan was presented to invest ¥100 million in molds for new products from September to December 2021. Research and development expenses were also ¥39.721 million. - FY2021-Q3AdvancedAnnual report
「Against this backdrop, the number of people awaiting discharge at home increased substantially as a result of hospitalization adjustments due to the spread of COVID-19, while efforts to expand sales of the main product Miolet III, an electric bed for nursing care, also progressed. As a result, sales in the welfare equipment distribution market during the cumulative third-quarter period rose 11.1% year on year to ¥4,055 million.」
Expanded sales of the main product Miolet III lifted cumulative third-quarter sales in the welfare equipment distribution market by 11.1% year on year to ¥4,055 million. - FY2021-Q2AdvancedAnnual report
「Against this backdrop, driven by strong sales of the Group's main product, Miolet III, an electric bed for nursing care, sales in the welfare equipment distribution market during the cumulative second-quarter period rose 12.2% year on year to ¥2,800 million.」
Strong sales of the main product Miolet III drove cumulative second-quarter sales in the welfare equipment distribution market up 12.2% year on year to ¥2,800 million. - FY2021-Q1AdvancedAnnual report
「Against this backdrop, restrictions on the provision of welfare equipment, including the installation of electric beds for nursing care in homes, in some regions were gradually eased after the lifting of the state of emergency, allowing business activities to proceed broadly as usual. As shipments of the Group's main product, Miolet III, an electric bed for nursing care, were strong, sales in the welfare equipment distribution market during the cumulative first-quarter period rose 13.1% year on year to ¥1,342 million.」
Restrictions on the provision of welfare equipment in some regions were eased, and strong shipments of the main product Miolet III drove sales in the welfare equipment distribution market up 13.1% year on year to ¥1,342 million. - FY2020Update to the investment plan for molds for new productsAnnual report
「Reporting company: Head office (Onojo, Fukuoka Prefecture); electric beds for medical and nursing care business; molds; ¥75 million; internal funds; August 2020 to November 2020」
A new plan was presented to invest ¥75 million in molds for new products from August to November 2020. - FY2020-Q3AdvancedAnnual report
「Against this backdrop, driven by strong sales of Miolet III, an electric bed for nursing care launched in November 2018, sales in the welfare equipment distribution market during the cumulative third-quarter period were up 11.0% year on year at ¥3,649 million.」
Strong sales of Miolet III, launched in November 2018, continued, and cumulative third-quarter sales in the welfare equipment distribution market rose 11.0% year on year to ¥3,649 million. - FY2020-Q2AdvancedAnnual report
「Against this backdrop, driven by strong sales of Miolet III, an electric bed for nursing care launched in November 2018, sales in the welfare equipment distribution market during the cumulative second-quarter period were up 14.1% year on year at ¥2,496 million.」
Against the backdrop of strong sales of Miolet III, launched in November 2018, cumulative second-quarter sales in the welfare equipment distribution market rose 14.1% year on year to ¥2,496 million. - FY2020-Q1AdvancedAnnual report
「Against this backdrop, driven by strong sales of Miolet III, an electric bed for nursing care launched in November 2018, sales in the welfare equipment distribution market during the cumulative first-quarter period were up 18.8% year on year at ¥1,186 million.」
Strong sales of Miolet III, launched in November 2018, continued, and sales in the welfare equipment distribution market rose 18.8% year on year to ¥1,186 million. - FY2019AdvancedAnnual report
「Capital expenditure by the Company and its consolidated subsidiaries is planned after comprehensive consideration of economic forecasts, industry trends, investment efficiency, and other factors. The major new construction and renovation projects planned as of the end of the consolidated fiscal year were as follows: Reporting company: Head office (Onojo, Fukuoka Prefecture); electric beds for medical and nursing care business; molds; ¥80 million; internal funds; January 2020 to March 2020」
A specific plan was presented to invest ¥80 million in molds for new products from January to March 2020. - FY2019-Q3AdvancedAnnual report
「Against this backdrop, sales in the welfare equipment distribution market declined year on year in the first quarter because the market was in a trough in the product life cycle. However, driven by strong sales of Miolet III, an electric bed for nursing care launched in November 2018, sales in the market during the cumulative third-quarter period were up 5.1% year on year at ¥3,289 million.」
Strong sales of Miolet III, launched in November 2018, continued, and cumulative third-quarter sales in the welfare equipment distribution market rose 5.1% year on year to ¥3,289 million. - FY2019-Q2AdvancedAnnual report
「Against this backdrop, sales in the welfare equipment distribution market declined year on year in the first quarter because the market was in a trough in the product life cycle. However, driven by strong sales of Miolet III, an electric bed for nursing care launched in November 2018, sales in the market during the cumulative second-quarter period were up 0.5% year on year at ¥2,188 million.」
Miolet III, an electric bed for nursing care, was launched in November 2018. Strong sales lifted sales in the welfare equipment distribution market by 0.5% year on year to ¥2,188 million. - FY2018AdvancedAnnual report
「As of the end of the consolidated fiscal year, the Company planned to install molds costing ¥50 million for a new electric bed for medical and nursing care at its head office from October 2018 to December 2018 as a major new construction and renovation project.」
A specific plan was presented to invest ¥50 million in molds for new products from October to December 2018. - FY2017AdvancedAnnual report
「The Group's total capital expenditure during the consolidated fiscal year was ¥148 million. The principal items were ¥122 million for molds for mass production of new products and ¥22 million for a business system to improve the efficiency of import operations.」
Capital expenditure supporting product development and mass production was carried out, including ¥122 million for molds for mass production of new products. - FY2016First statedAnnual report
「In addition to improving quality and functionality while thoroughly managing costs by optimizing our overseas production system, we will work to strengthen our product development capabilities by also enhancing our marketing and design capabilities.」
Product development initiatives combining production, quality, cost, marketing, and design.